CJC-1295 (No DAC) / GHRP-2 Blend — Complete Dosing Protocol & Guide
Research-based dosing, cycling, stacking, and side effects for muscle growth protocols.
Category
🏋️ Muscle Growth
Route
Subcutaneous
Half-life
~30 min (CJC) + ~30 min (GHRP-2)
Frequency
2-3x daily
Cycle length
8-12 weeks
Dose range
200 mcg–600 mcg / dose
What is CJC-1295 (No DAC) / GHRP-2 Blend?
GHRH + GHRP synergy without the extreme hunger of GHRP-6 — CJC-1295 amplifies the GH pulse while GHRP-2 triggers a stronger, cleaner GH release. In the research literature, CJC-1295 (No DAC) / GHRP-2 Blend is classified as a muscle growth peptide — it fits the gh boosting, strength, body composition category.
Typically 100-300mcg of each per injection (combined dose shown). GHRP-2 is slightly more potent than GHRP-6 with much less hunger impact. Dose on an empty stomach.
In laboratory and clinical research settings, CJC-1295 (No DAC) / GHRP-2 Blend is administered subcutaneous at a frequency of 2-3x daily. Its elimination half-life is ~30 min (CJC) + ~30 min (GHRP-2), which is what shapes the 2-3x daily dosing cadence. Typical research protocols dose at approximately 4 mcg/kg of body weight, giving a working range of 200 mcg–600 mcg per administration.
CJC-1295 (No DAC) / GHRP-2 Blend Dosing Protocol
Research protocols dose CJC-1295 (No DAC) / GHRP-2 Blend at approximately 4 mcg/kg of body weight, which puts the per-administration range at 200 mcg–600 mcg. The table below shows how that scales with experience level for an 80 kg (176 lb) adult.
| Level | Dose (80 kg example) | Notes |
|---|---|---|
| Beginner | 160 mcg | First cycle — start at the low end |
| Intermediate | 240 mcg | 1–3 prior cycles, tolerating the range |
| Advanced | 320 mcg | Multiple cycles — research protocols only |
Dose calculation formula
dose (mcg) = 4 mcg/kg × body weight (kg) × experience factor
Experience factors for CJC-1295 (No DAC) / GHRP-2 Blend: beginner ×0.5, intermediate ×0.75, advanced ×1. Doses outside the 200 mcg–600 mcg research range are not studied.
Titration & protocol notes
Typically 100-300mcg of each per injection (combined dose shown). GHRP-2 is slightly more potent than GHRP-6 with much less hunger impact. Dose on an empty stomach.
Weight, goal, and safety screening included
CJC-1295 (No DAC) / GHRP-2 Blend Cycle & Break: 8-12 weeks on, then 4 weeks off
Recommended cycle
8-12 weeks
Recommended break
4 weeks off
Why cycling matters for CJC-1295 (No DAC) / GHRP-2 Blend
- Pituitary desensitization: growth-hormone-releasing peptides lose effectiveness as the pituitary becomes less responsive to repeated stimulation — cycling preserves the GH pulse amplitude.
- Side-effect management: water retention, tingling, and cortisol/prolactin elevation associated with GH secretagogues fade during off periods.
- Assessment windows: research protocols use the break to evaluate results — how much of the benefit persisted, and whether another cycle is justified — before re-exposing.
What happens during the break
- Receptor resensitization: the biological targets regain baseline sensitivity, so the next cycle starts from full responsiveness.
- Biomarker normalization: hormone, metabolic, and inflammatory markers measured during research protocols return toward baseline.
- Consolidation: benefits built during the cycle (tissue repair, body composition, sleep quality) are consolidated through sleep, nutrition, and training rather than pharmacological stimulation.
- Reassessment: this is the window to re-run the PeptideWise protocol engine — your weight, goals, or safety profile may have changed.
Stacking CJC-1295 (No DAC) / GHRP-2 Blend
Yes — CJC-1295 (No DAC) / GHRP-2 Blend stacks well with Ipamorelin in research protocols. Good stacks combine peptides that act through different mechanisms on the same goal, rather than doubling up on one pathway.
When stacking, keep cycle lengths aligned (8-12 weeks for CJC-1295 (No DAC) / GHRP-2 Blend), stagger or combine doses to fit both peptides' frequencies, and introduce one new peptide at a time so individual responses stay interpretable.
Peptides that stack with CJC-1295 (No DAC) / GHRP-2 Blend
CJC-1295 (No DAC) / GHRP-2 Blend Side Effects & Safety
Reported side effects
- Mild hunger increase
- Water retention
- Flushing
- Mild hyperglycemia
Most effects are dose-dependent — reduce the dose or pause if they persist.
Contraindicated with
- Cancer
- Active tumor
- Pregnant
- Breastfeeding
- Untreated thyroid disorder
- Diabetes
The protocol engine removes contraindicated peptides automatically.
Research use only — read before starting
CJC-1295 (No DAC) / GHRP-2 Blend is sold for research purposes only and is not FDA-approved as a supplement or consumer product. Nothing on this page is medical advice. Severe reactions (chest pain, severe abdominal pain, breathing difficulty, signs of allergy) mean stop immediately and seek medical evaluation. Consult a qualified healthcare provider before starting any peptide protocol — especially with the conditions and medications listed above.
CJC-1295 (No DAC) / GHRP-2 Blend FAQ
What is CJC-1295 (No DAC) / GHRP-2 Blend?
CJC-1295 (No DAC) / GHRP-2 Blend is a muscle growth peptide — the muscle growth category covers gh boosting, strength, body composition. GHRH + GHRP synergy without the extreme hunger of GHRP-6 — CJC-1295 amplifies the GH pulse while GHRP-2 triggers a stronger, cleaner GH release. In research settings it is administered subcutaneous at a frequency of 2-3x daily, with an elimination half-life of ~30 min (CJC) + ~30 min (GHRP-2) and a studied dose range of 200 mcg–600 mcg per administration (about 4 mcg/kg of body weight).
How does CJC-1295 (No DAC) / GHRP-2 Blend work?
GHRH + GHRP synergy without the extreme hunger of GHRP-6 — CJC-1295 amplifies the GH pulse while GHRP-2 triggers a stronger, cleaner GH release. That mechanism places it in the muscle growth category. Pharmacokinetically, its elimination half-life of ~30 min (CJC) + ~30 min (GHRP-2) is what shapes the 2-3x daily dosing cadence used in research protocols, and the full effect builds across a 8-12 weeks cycle followed by 4 weeks off — which is why the dosing is cycled rather than continuous.
How to take CJC-1295 (No DAC) / GHRP-2 Blend?
CJC-1295 (No DAC) / GHRP-2 Blend is taken subcutaneous — subcutaneous injection into abdominal fat is the standard research route. The research-standard frequency is 2-3x daily, with a half-life of ~30 min (CJC) + ~30 min (GHRP-2). Take it on an empty stomach (no food 30–60 minutes before or after), since carbohydrates and fats blunt the GH pulse. Always start at the low end of the dose range, use aseptic technique for injections, and follow the 8-12 weeks cycle followed by 4 weeks off. PeptideWise calculates the exact dose and schedule for your body weight and goal.
How much CJC-1295 (No DAC) / GHRP-2 Blend should I take?
Research protocols use 200 mcg–600 mcg per administration, weight-based at roughly 4 mcg/kg of body weight, administered 2-3x daily. For an 80 kg (176 lb) adult that works out to about 160 mcg for a beginner, 240 mcg for an intermediate, and 320 mcg for an advanced research protocol. Start at the bottom of the range and titrate up only while the response is tolerable — the personalized protocol engine on this site computes the exact figure for your weight.
How long should I cycle CJC-1295 (No DAC) / GHRP-2 Blend?
The standard research cycle is 8-12 weeks, followed by 4 weeks off. Cycling matters because continuous exposure leads to receptor desensitization (tachyphylaxis) — the same dose produces less effect over time — and side effects fade during off periods. Don't extend the cycle past 8-12 weeks chasing diminishing returns.
Can I stack CJC-1295 (No DAC) / GHRP-2 Blend with other peptides?
Yes. CJC-1295 (No DAC) / GHRP-2 Blend is commonly researched alongside Ipamorelin. The best stacks pair peptides that act through different mechanisms toward the same goal — for example BPC-157 (angiogenesis) with TB-500 (cell migration). Introduce one peptide at a time, align cycle lengths, and cap stacks at 2–3 peptides so effects stay attributable. The protocol engine on this site only recommends stack combinations that pass safety screening for your conditions and medications.
What are the side effects of CJC-1295 (No DAC) / GHRP-2 Blend?
Reported in research and trial settings: mild hunger increase; water retention; flushing; mild hyperglycemia. Most are dose-dependent and resolve when the dose is reduced or the cycle ends. If any severe reaction occurs (chest pain, severe abdominal pain, difficulty breathing, signs of an allergic response), stop immediately and seek medical evaluation.
Is CJC-1295 (No DAC) / GHRP-2 Blend safe?
CJC-1295 (No DAC) / GHRP-2 Blend carries a good research safety profile at the doses described above, but safety is individual. It is contraindicated in research settings with: cancer, active tumor, pregnant, breastfeeding, untreated thyroid disorder, diabetes. It is not medical advice to run any peptide without supervision — consult a qualified healthcare provider who knows your full history first, get baseline labs, and re-check during the cycle. 🏋️ As a muscle growth peptide, CJC-1295 (No DAC) / GHRP-2 Blend is sold for research use only.
Where to buy CJC-1295 (No DAC) / GHRP-2 Blend?
CJC-1295 (No DAC) / GHRP-2 Blend is sold by research-chemical suppliers for laboratory research use only — it is not an approved dietary supplement or consumer product, and regulations vary by country and jurisdiction. Before considering any source: (1) consult a licensed healthcare provider about medically supervised options, (2) if purchasing for research, verify third-party certificates of analysis (COA) confirming purity and identity, and (3) be wary of prices that look too good to be true — they usually are. PeptideWise does not sell peptides; we provide dosing research and protocol tools.
How to reconstitute CJC-1295 (No DAC) / GHRP-2 Blend?
CJC-1295 (No DAC) / GHRP-2 Blend ships lyophilized (freeze-dried) and must be reconstituted before use. Use bacteriostatic water: inject it slowly down the inside wall of the vial (never directly onto the powder), then swirl gently — never shake, as shaking denatures the peptide. Example: a 5 mg vial + 2 mL of bacteriostatic water gives 2.5 mg/mL, so a 250 mcg dose is 10 units (0.1 mL) on an insulin syringe. Store the reconstituted vial refrigerated at 2–8°C and use within 2–4 weeks. See the full step-by-step reconstitution guide for concentration math and storage.
Continue reading
Disclaimer: This page is research and educational information only, not medical advice. CJC-1295 (No DAC) / GHRP-2 Blend is sold for laboratory research use and is not approved for human consumption. Doses, cycles, and stacking information summarize published research and community protocol reports — individual risk depends on your health status, medications, and supervision. Consult a qualified healthcare provider before considering any peptide protocol. PeptideWise does not sell peptides and has no financial relationship with any supplier.
Get your personalized CJC-1295 (No DAC) / GHRP-2 Blend protocol
Enter your weight, goal, and safety profile — the protocol engine calculates your exact CJC-1295 (No DAC) / GHRP-2 Blenddose, builds the cycle calendar, and screens every recommendation against your conditions and medications.
Build my CJC-1295 (No DAC) / GHRP-2 Blend protocol